LOGIN 
With offices across the globe, GPI is one of the world’s most trusted pharmaceutical data and analytics companies. Whether you’re a global, midsize or emerging pharmaceutical company, we can help you find answers to the most common or complex problems, supported by the latest data, detailed visualisations and industry expert guidance.
Talk to a senior consultant today for strategic
advice and insight
Our qualified market experts can help you achieve commercial success.
Explore ServicesNeed answers to your market access
challenges? We’re ready to help
Our market access and pricing solutions are flexible. We tailor solutions to match
your business requirements, and allow you to identify opportunities,
pivot quicky, and act fast.
Competitively priced
Our analysts tailor datasets to your unique needs, ensuring you pay only for what you use.
Enabling decisions with advanced analytics
All the data you need is accessible in one place, with real-time analytics and scenario modelling to help you make strategic decisions fast.
Exceed expectations
Get access to payer insights and build TPPs that outperform the competition.
Experts on demand
We’ve done this before. We have helped organisations of all sizes evaluate the competitive landscape and successfully launch new drugs into the market.
Would you like a 30 min consult with a trusted expert
Book a Consultation
Meticulous analysis for your business
challenges
We understand that individuals, teams and functional areas have unique demands.
Engage GPI to help challenging projects in specialised areas, for faster insights.
What-if questions
Quickly prepare market analysis and pricing using scenario modelling.
Enable commercial due diligence
Get an independent assessment of market potential and validation of market decisions.
Inform internal budgets
Estimate a drug's potential revenue based on its pricing potential.
Complete market access data
Our independently verified data complements your existing environment. Securely and confidentially use your own data together with our proprietary data, in our award-winning platform to create impactful visualisations and narratives.
Competitive intelligence
anticipate pricing pressures and make informed decisions on pricing models, reimbursement negotiations, and market positioning.
Would you like a 30 min consult with a trusted expert
Book a ConsultationDomain expertise for emerging pharmaceutical companies
We’re an extension of your team. We assist emerging pharmaceutical companies using data, analytics and insight, to help assess opportunities at every stage of your market access and pricing journey.
Early insights
Assess commercial potential, as early as the clinical development phase. We help estimate the price potential of products, including orphan drugs, when there are no direct competitors.
Tune your product to market needs
Know what payers value and use this to help your development team design your trials. Strengthen approval chances by demonstrating differentiation and value-based health impact.
Risk management
Our specialist services can help you to avoid hurdles along the way. We have expertise in trial optimisation, comparator availability, pricing strategies and HTA pathways.
Launch success
Successful commercialisation is our end game. Smooth your path to market with our agile approach and the right advice.
Would you like a 30 min consult with a trusted expert
Book a Consultation
The three essentials for opportunity assessments
Opportunity Assessments are a vital step for in-licensing new pipeline products or making go/no-go decisions around the clinical development of early-stage assets. To be able to achieve a reliable opportunity assessment it requires three essential parts which lead to the final output. The Correct Analogue Basket Having a thought-through analogue basket is probably the most essential […]
Read More
GPI’s latest innovation, pulse™ 2.0 leads the way…
GPI pulse™ is a dynamic value, price, and access data analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. The data analytics platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access […]
Read More
GPI developed price and product allocation strategy
GPI developed price and product allocation strategy
Read More
GPI Company Values – Change is Good
GPI drives effective and efficient access to medicines with faster insights and sustainable pricing strategies. We love what we do and our work is always reflective of our company values: authenticity, sustainability, quality matters, and change is good. At GPI, we like to walk the walk as well as talk the talk. With that in […]
Read More
GPI’s Agile approach to project management helps to ensure project success
GPI ScrumMaster Stephen Jeffries describes how GPI’s agile approach aids teamworking, collaboration and project excellence. Joining a new organisation is always a challenging time. Understanding the company culture, learning new systems, technology and quickly coming up to speed with fast-moving projects. GPI is no exception, as their new ScrumMaster, listening to how the GPI teams […]
Read More
GPI supports multinational biopharmaceutical company in forecasting their early-stage assets’ commercial opportunities
GPI supported a large biopharmaceutical company in forecasting their early-stage assets.
Read More
Early Pricing and Market Access Forecasting for Orphan Assets
Leveraging a Value-Driven Approach to Price Forecasting GPI’s Eva Barkhauskaite, Rachel Jao, Preeti Patel and Tom Brockbank look at early pricing and market access forecasting for orphan assets. The research takes an analytical approach to asset price forecasting, and price value optimisation, designed to empower pricing and market access strategy. Objectives Orphan products could contribute […]
Read More
GPI horizon representing disruptive innovation in the consulting industry
Conducted by CBI Insights (Killing Strategy: the disruption of management consulting) this piece highlights the disruption of management consulting and how companies are responding, aiming for the perfect consultant/client relationship. It describes how technological innovation has driven change in the management consulting industry, disrupting the traditional methods and forcing the consulting industry to change. The […]
Read More
Net price forecasting and launch optimisation for an IO asset on UK oncology indication expansion for top tier pharmaceutical
Leveraging our data and analytics platform and proprietary methodology we provided a large pharmaceutical company with net price forecasting and launch optimisation for an IO asset.
Read More